401 related articles for article (PubMed ID: 2999343)
1. Immune response to Epstein-Barr virus (EBV) in ataxia-telangiectasia: EBV-specific antibody patterns and their relation to cell-mediated immunity.
Berkel AI; Henle W; Henle G; Ersoy F; Sanal O; Klein G; Yeğin O
Kroc Found Ser; 1985; 19():287-300. PubMed ID: 2999343
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus-related antibody patterns in ataxia-telangiectasia.
Berkel AI; Henle W; Henle G; Klein G; Ersoy F; Sanal O
Clin Exp Immunol; 1979 Feb; 35(2):196-201. PubMed ID: 219976
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus antibodies in patients with ataxia-telangiectasia and other immunodeficiency diseases.
Joncas JH; Wills A; Reece E; Fox Z
Can Med Assoc J; 1981 Oct; 125(8):845-9. PubMed ID: 6272957
[TBL] [Abstract][Full Text] [Related]
4. [Studies on Epstein-Barr virus (EBV) infection and reactivity of peripheral B lymphocytes to EBV in patients with ataxia telangiectasia].
Okano M
Hokkaido Igaku Zasshi; 1986 Jul; 61(4):584-92. PubMed ID: 3019855
[TBL] [Abstract][Full Text] [Related]
5. Immunological characterization of Hodgkin's and non-Hodgkin's lymphoma patients with high antibody titers against Epstein-Barr virus-associated antigens.
Masucci G; Mellstedt H; Masucci MG; Szigeti R; Ernberg I; Björkholm M; Tsukuda K; Henle G; Henle W; Pearson G
Cancer Res; 1984 Mar; 44(3):1288-300. PubMed ID: 6318984
[TBL] [Abstract][Full Text] [Related]
6. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.
Shao JY; Li YH; Gao HY; Wu QL; Cui NJ; Zhang L; Cheng G; Hu LF; Ernberg I; Zeng YX
Cancer; 2004 Mar; 100(6):1162-70. PubMed ID: 15022282
[TBL] [Abstract][Full Text] [Related]
7. Serological follow-up study on the antibody levels to Epstein-Barr virus-determined nuclear antigen (EBNA) patients with nasopharyngeal carcinoma (NPC) after radiation therapy.
Shimakage M; Ikegami N; Chatani M; Yoshino K; Sato T
Biken J; 1987 Jun; 30(2):45-51. PubMed ID: 2830879
[TBL] [Abstract][Full Text] [Related]
8. Seroepidemiological study of relationships between Epstein-Barr virus and rheumatoid arthritis.
Ferrell PB; Aitcheson CT; Pearson GR; Tan EM
J Clin Invest; 1981 Mar; 67(3):681-7. PubMed ID: 6259207
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr serology in immunodeficiencies: an attempt to correlate with immune abnormalities in Wiskott-Aldrich and Chediak-Higashi syndromes and ataxia telangiectasia.
Vilmer E; Lenoir GM; Virelizier JL; Griscelli C
Clin Exp Immunol; 1984 Feb; 55(2):249-56. PubMed ID: 6321070
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus-related antibody pattern in uveitis.
Sunakawa M; Okinami S
Jpn J Ophthalmol; 1985; 29(4):423-8. PubMed ID: 3007826
[TBL] [Abstract][Full Text] [Related]
11. Immune deficiency in the X-linked lymphoproliferative syndrome. I. Epstein-Barr virus-specific defects.
Harada S; Sakamoto K; Seeley JK; Lindsten T; Bechtold T; Yetz J; Rogers G; Pearson G; Purtilo DT
J Immunol; 1982 Dec; 129(6):2532-5. PubMed ID: 6292290
[TBL] [Abstract][Full Text] [Related]
12. Complementary serum test of antibodies to Epstein-Barr virus nuclear antigen-1 and early antigen: a possible alternative for primary screening of nasopharyngeal carcinoma.
Chang KP; Hsu CL; Chang YL; Tsang NM; Chen CK; Lee TJ; Tsao KC; Huang CG; Chang YS; Yu JS; Hao SP
Oral Oncol; 2008 Aug; 44(8):784-92. PubMed ID: 18206420
[TBL] [Abstract][Full Text] [Related]
13. Nasopharyngeal carcinoma: the diagnostic value of the antibody-dependent, cellular cytotoxicity test and of EBV serology.
Faggioni A; Corradini C; Venanzoni M; Cardi G; Bevere F; Barile G; Zompetta C; Frati L
J Exp Pathol; 1987; 3(4):471-7. PubMed ID: 2842480
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus (EBV) antibodies in children with non-Hodgkin's lymphomas.
Roubalová K; Weinreb M; Roubal J; Kodet R; Koutecký J; Vonka V
Acta Virol; 1988 Jul; 32(4):339-48. PubMed ID: 2903639
[TBL] [Abstract][Full Text] [Related]
15. High incidence of elevated antibody titers to Epstein-Barr virus in patients with uveitis.
Touge C; Agawa H; Sairenji T; Inoue Y
Arch Virol; 2006 May; 151(5):895-903. PubMed ID: 16362642
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus in pediatric patients after renal transplantation.
Schwab M; Böswald M; Korn K; Ruder H
Clin Nephrol; 2000 Feb; 53(2):132-9. PubMed ID: 10711415
[TBL] [Abstract][Full Text] [Related]
17. The serological signs of the Epstein-Barr virus (EBV) activity in the elderly.
Ternák G; Szúcs G; Uj M
Acta Microbiol Immunol Hung; 1997; 44(2):133-40. PubMed ID: 9330661
[TBL] [Abstract][Full Text] [Related]
18. Increased anti-Epstein-Barr virus antibodies in epidermotropic cutaneous T-cell lymphoma: a study of 64 patients.
Jumbou O; Mollat C; N'Guyen JM; Billaudel S; Litoux P; Dréno B
Br J Dermatol; 1997 Feb; 136(2):212-6. PubMed ID: 9068734
[TBL] [Abstract][Full Text] [Related]
19. Relationship between clinical stage, histopathology and antibody titers against the second Epstein-Barr virus nuclear antigen (EBNA-2) in non-Hodgkin's lymphoma patients.
Masucci G; Mellstedt H; Henle G; Henle W; Rymo L; Masucci MG; Ernberg I; Klein G
Int J Cancer; 1989 Jun; 43(6):1017-21. PubMed ID: 2543639
[TBL] [Abstract][Full Text] [Related]
20. Antibodies to Epstein-Barr virus-specific DNase and DNA polymerase in the chronic fatigue syndrome.
Jones JF; Williams M; Schooley RT; Robinson C; Glaser R
Arch Intern Med; 1988 Sep; 148(9):1957-60. PubMed ID: 2843138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
